Sialidosis type 1

Sialidosis type 1, also known as cherry-red spot myoclonus syndrome or normosomatic sialidosis, is a rare autosomal recessive lysosomal storage disorder caused by mutations in the NEU1 gene, which encodes the enzyme neuraminidase 1 (also called sialidase). Deficiency of this enzyme leads to the accumulation of sialylated glycoproteins and oligosaccharides in tissues throughout the body. Sialidosis type 1 is considered the milder, attenuated form of sialidosis, distinguished from the more severe type 2 form by the absence of dysmorphic features and skeletal abnormalities. The disease primarily affects the nervous system and the eyes. The hallmark clinical features are bilateral cherry-red spots of the macula (visible on ophthalmologic examination) and progressive myoclonus — sudden, involuntary muscle jerks that can be debilitating. Patients typically develop symptoms in the second or third decade of life, though onset can range from adolescence to early adulthood. Additional neurological features may include progressive visual impairment, ataxia (impaired coordination), seizures, and tremor. Cognitive function is generally preserved or only mildly affected, which distinguishes this form from sialidosis type 2. Some patients may also develop hyperreflexia and gait difficulties as the disease progresses. There is currently no cure or disease-specific treatment for sialidosis type 1. Management is primarily supportive and symptomatic, focusing on controlling myoclonus and seizures with antiepileptic medications, though myoclonus can be difficult to manage and may become refractory to treatment over time. Ophthalmologic monitoring is recommended. Research into potential therapies, including enzyme replacement and gene therapy approaches, is ongoing but no approved targeted treatments are available at this time. The disease follows a slowly progressive course, and life expectancy may be near normal in some patients, though quality of life can be significantly impacted by progressive myoclonus.

Common questions about Sialidosis type 1